UB Paderborn / Katalog / Suche / in CDI

National reflection on organs-on-chip for drug development: new regulatory challenges

Toxicology letters, 2023-10, Vol.388, p.1-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics

Nephrology, dialysis, transplantation, 2023-07, Vol.38 (8), p.1918-1920

2023

Link zum Volltext

Verfügbarkeit prüfen

Emerging drugs of abuse: current perspectives on synthetic cannabinoids

Substance abuse and rehabilitation, 2015-01, Vol.6 (default), p.113-129

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis

Expert opinion on drug metabolism & toxicology, 2016-03, Vol.12 (3), p.327-344

2016

Link zum Volltext

Verfügbarkeit prüfen

Synthetic cannabinoid (K2) use in pediatric patients and cardiovascular events: A place for pericarditis and myopericarditis?

The Journal of pediatrics, 2015-12, Vol.167 (6), p.1454-1454

2015

Link zum Volltext

Verfügbarkeit prüfen

Warning on increased serious health complications related to non-medical use of nitrous oxide

Therapie, 2021-09, Vol.76 (5), p.478-479

2021

Link zum Volltext

Verfügbarkeit prüfen

Emerging drugs of abuse: current perspectives on substituted cathinones

Substance abuse and rehabilitation, 2014-01, Vol.5 (default), p.37-52

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study

Peritoneal dialysis international, 2018-11, Vol.38 (6), p.463-466

2018

Link zum Volltext

Verfügbarkeit prüfen

New Synthetic Drugs in Addictovigilance

Therapie, 2015-03, Vol.70 (2), p.179-189

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Five Benzodiazepine-Receptor Agonists on Buprenorphine-Induced µ-Opioid Receptor Regulation

Journal of Pharmacological Sciences, 2009, Vol.110(1), pp.36-46

2009

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and in vitro characterization of trans- and cis-[18F]-4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]-3-fluoropiperidine-1-carboxylates as new potential PET radiotracer candidates for the NR2B subtype N-methyl-d-aspartate receptor

European journal of medicinal chemistry, 2012-07, Vol.53, p.408-415

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses

Clinical pharmacokinetics, 1997-07, Vol.33 (1), p.52-77

DEBRUYNE, D

1997

Link zum Volltext

Verfügbarkeit prüfen

Interaction between clozapine and oxcarbazepine: a case report

Therapeutic advances in psychopharmacology, 2017-02, Vol.7 (2), p.95-99

2017

Link zum Volltext

Verfügbarkeit prüfen

Radiolabelling of 1,4-disubstituted 3-[18F]fluoropiperidines and its application to new radiotracers for NR2B NMDA receptor visualization

Organic & biomolecular chemistry, 2012-11, Vol.10 (42), p.8493-8500

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Intraperitoneal Daptomycin in Patients with Peritoneal Dialysis-Related Peritonitis

Peritoneal dialysis international, 2017-01, Vol.37 (1), p.44-50

2017

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, evaluation and metabolic studies of radiotracers containing a 4-(4-[18F]-fluorobenzyl)piperidin-1-yl moiety for the PET imaging of NR2B NMDA receptors

European journal of medicinal chemistry, 2011-06, Vol.46 (6), p.2295-2309

2011

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the APOMYGRE trial

Transplantation, 2010-05, Vol.89 (10), p.1255

2010

Link zum Volltext

Verfügbarkeit prüfen

The current aspects of the use of ecstasy/MDMA in France

Therapie, 2016-12, Vol.71 (6), p.553-562

2016

Link zum Volltext

Verfügbarkeit prüfen

Comment on “A Unique Case of Cardiac Arrest following K2 Abuse”

Case reports in cardiology, 2015-01, Vol.2015, p.739149-2

2015

Link zum Volltext

Verfügbarkeit prüfen

Daptomycin Compatibility in Peritoneal Dialysis Solutions

Peritoneal dialysis international, 2011-07, Vol.31 (4), p.492-495

2011

Link zum Volltext

Verfügbarkeit prüfen

In vitro stability of fortified ophthalmic antibiotics stored at -20 degrees C for 6 months

Cornea, 2010-07, Vol.29 (7), p.807

2010

Link zum Volltext

Verfügbarkeit prüfen

Competitive displacement binding assay on rat brain sections and using a β-imager: Application to μ-opioid ligands

Journal of neuroscience methods, 2006-06, Vol.154 (1), p.60-67

2006

Link zum Volltext

Verfügbarkeit prüfen

Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouse

Drug and alcohol dependence, 2006-11, Vol.85 (2), p.103-113

2006

Link zum Volltext

Verfügbarkeit prüfen

[11 C]-MeJDTic: a novel radioligand for κ-opioid receptor positron emission tomography imaging

Nuclear medicine and biology, 2008-07, Vol.35 (5), p.561-569

2008

Link zum Volltext

Verfügbarkeit prüfen

Mephedrone: a designer drug of recent use in France

Therapie, 2010-11, Vol.65 (6), p.519-524

2010

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

National reflection on organs-on-chip for drug development: new regulatory challenges

Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics

Emerging drugs of abuse: current perspectives on synthetic cannabinoids

Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis

Synthetic cannabinoid (K2) use in pediatric patients and cardiovascular events: A place for pericarditis and myopericarditis?

Warning on increased serious health complications related to non-medical use of nitrous oxide

Emerging drugs of abuse: current perspectives on substituted cathinones

Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study

New Synthetic Drugs in Addictovigilance

Comparison of Five Benzodiazepine-Receptor Agonists on Buprenorphine-Induced µ-Opioid Receptor Regulation

Synthesis and in vitro characterization of trans- and cis-[18F]-4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]-3-fluoropiperidine-1-carboxylates as new potential PET radiotracer candidates for the NR2B subtype N-methyl-d-aspartate receptor

Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses

Interaction between clozapine and oxcarbazepine: a case report

Radiolabelling of 1,4-disubstituted 3-[18F]fluoropiperidines and its application to new radiotracers for NR2B NMDA receptor visualization

Pharmacokinetics of Intraperitoneal Daptomycin in Patients with Peritoneal Dialysis-Related Peritonitis

Synthesis, evaluation and metabolic studies of radiotracers containing a 4-(4-[18F]-fluorobenzyl)piperidin-1-yl moiety for the PET imaging of NR2B NMDA receptors

Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the APOMYGRE trial

The current aspects of the use of ecstasy/MDMA in France

Comment on “A Unique Case of Cardiac Arrest following K2 Abuse”

Daptomycin Compatibility in Peritoneal Dialysis Solutions

In vitro stability of fortified ophthalmic antibiotics stored at -20 degrees C for 6 months

Competitive displacement binding assay on rat brain sections and using a β-imager: Application to μ-opioid ligands

Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouse

[11 C]-MeJDTic: a novel radioligand for κ-opioid receptor positron emission tomography imaging

Mephedrone: a designer drug of recent use in France

Suchergebnisse filtern